Literature DB >> 20074595

Triggered content release from optimized stealth thermosensitive liposomes using mild hyperthermia.

Li Li1, Timo L M ten Hagen, Debby Schipper, Tom M Wijnberg, Gerard C van Rhoon, Alexander M M Eggermont, Lars H Lindner, Gerben A Koning.   

Abstract

Liposomes are potent nanocarriers to deliver chemotherapeutic drugs to tumors. However, the inefficient drug release hinders their application. Thermosensitive liposomes (TSL) can release drugs upon heat. This study aims to identify the optimum 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-PEG(2000) (DSPE-PEG(2000)) concentration in stealth TSL to improve content release efficiency under mild hyperthermia (HT). TSL were prepared with DSPE-PEG(2000) from 1 to 10 mol%, around 80 nm in size. Quenched carboxyfluorescein (CF) in aqueous phase represented encapsulated drugs. In vitro temperature/time-dependent CF release and TSL stability in serum were quantified by fluorometry. In vivo CF release in dorsal skin flap window chamber models implanted with human BLM melanoma was captured by confocal microscopy. In vitro heat triggered CF release increased with increasing DSPE-PEG(2000) density. However, 6 mol% and higher DSPE-PEG(2000) caused CF leakage at physiological temperature. TSL with 5 mol% DSPE-PEG(2000) were stable at 37 degrees C, while released 60% CF in 1 min and almost 100% CF in 1h at 42 degrees C. In vivo optical intravital imaging showed immediate massive CF release above 41 degrees C. In conclusion, incorporation of 5 mol% DSPE-PEG(2000) optimized stealth TSL content release triggered by HT. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20074595     DOI: 10.1016/j.jconrel.2010.01.006

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  46 in total

1.  Targeted drug delivery by high intensity focused ultrasound mediated hyperthermia combined with temperature-sensitive liposomes: computational modelling and preliminary in vivovalidation.

Authors:  Astrid Gasselhuber; Matthew R Dreher; Ari Partanen; Pavel S Yarmolenko; David Woods; Bradford J Wood; Dieter Haemmerich
Journal:  Int J Hyperthermia       Date:  2012       Impact factor: 3.914

2.  Selective non-covalent triggered release from liposomes.

Authors:  Adam J Plaunt; Meghan B Courbanou; Katrina D Cuison; Kara M Harmatys; Bradley D Smith
Journal:  Chem Commun (Camb)       Date:  2012-07-09       Impact factor: 6.222

3.  Near-infrared light-sensitive liposomes for the enhanced photothermal tumor treatment by the combination with chemotherapy.

Authors:  Jian You; Peizun Zhang; Fuqiang Hu; Yongzhong Du; Hong Yuan; Jiang Zhu; Zuhua Wang; Jialin Zhou; Chun Li
Journal:  Pharm Res       Date:  2014-03       Impact factor: 4.200

Review 4.  Molecular aptamers for drug delivery.

Authors:  Weihong Tan; Hui Wang; Yan Chen; Xiaobing Zhang; Haizhen Zhu; Chaoyong Yang; Ronghua Yang; Chen Liu
Journal:  Trends Biotechnol       Date:  2011-08-06       Impact factor: 19.536

5.  Nanoscale Drug Delivery and Hyperthermia: The Materials Design and Preclinical and Clinical Testing of Low Temperature-Sensitive Liposomes Used in Combination with Mild Hyperthermia in the Treatment of Local Cancer.

Authors:  Chelsea D Landon; Ji-Young Park; David Needham; Mark W Dewhirst
Journal:  Open Nanomed J       Date:  2011-01-01

6.  Mild hyperthermia with magnetic resonance-guided high-intensity focused ultrasound for applications in drug delivery.

Authors:  Ari Partanen; Pavel S Yarmolenko; Antti Viitala; Sunil Appanaboyina; Dieter Haemmerich; Ashish Ranjan; Genevieve Jacobs; David Woods; Julia Enholm; Bradford J Wood; Matthew R Dreher
Journal:  Int J Hyperthermia       Date:  2012       Impact factor: 3.914

Review 7.  Nanoparticles and nanothermia for malignant brain tumors, a suggestion of treatment for further investigations.

Authors:  Cristina Prieto; Isabel Linares
Journal:  Rep Pract Oncol Radiother       Date:  2018-09-06

8.  Short-chain glycoceramides promote intracellular mitoxantrone delivery from novel nanoliposomes into breast cancer cells.

Authors:  Lília R Cordeiro Pedrosa; Timo L M Ten Hagen; Regine Süss; Albert van Hell; Alexander M M Eggermont; Marcel Verheij; Gerben A Koning
Journal:  Pharm Res       Date:  2014-10-16       Impact factor: 4.200

9.  Temperature-sensitive liposome-mediated delivery of thrombolytic agents.

Authors:  Vishal Saxena; Carmen Gacchina Johnson; Ayele H Negussie; Karun V Sharma; Matthew R Dreher; Bradford J Wood
Journal:  Int J Hyperthermia       Date:  2015-03-13       Impact factor: 3.914

10.  Hyperthermia and thermosensitive liposomes for improved delivery of chemotherapeutic drugs to solid tumors.

Authors:  Gerben A Koning; Alexander M M Eggermont; Lars H Lindner; Timo L M ten Hagen
Journal:  Pharm Res       Date:  2010-04-28       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.